Form 8-K - Current report:
SEC Accession No. 0001398733-25-000027
Filing Date
2025-11-05
Accepted
2025-11-05 16:04:15
Documents
25
Period of Report
2025-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20251105.htm   iXBRL 8-K 30891
2 EX-99.1 q32025-ex991earningsrelease.htm EX-99.1 238733
3 EX-99.2 q32025supplementalearnin.htm EX-99.2 16482
7 aqstlogo.jpg GRAPHIC 14528
8 q32025supplementalearnin001.jpg GRAPHIC 104223
9 q32025supplementalearnin002.jpg GRAPHIC 289531
10 q32025supplementalearnin003.jpg GRAPHIC 144682
11 q32025supplementalearnin004.jpg GRAPHIC 124417
12 q32025supplementalearnin005.jpg GRAPHIC 72269
13 q32025supplementalearnin006.jpg GRAPHIC 40272
14 q32025supplementalearnin007.jpg GRAPHIC 69829
15 q32025supplementalearnin008.jpg GRAPHIC 92240
16 q32025supplementalearnin009.jpg GRAPHIC 64162
17 q32025supplementalearnin010.jpg GRAPHIC 37241
  Complete submission text file 0001398733-25-000027.txt   1881943

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20251105.xsd EX-101.SCH 1776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20251105_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20251105_pre.xml EX-101.PRE 12504
27 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20251105_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 251453821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)